Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-28T23:41:21.745Z Has data issue: false hasContentIssue false

15 - Cosmetic uses of botulinum toxin A

Published online by Cambridge University Press:  02 December 2009

By
Kenneth Beer ,
Joel L. Cohen  and
Alastair Carruthers
Edited by
Anthony B. Ward  and
Michael P. Barnes
Kenneth Beer
Affiliation:
Palm Beach Esthetic Center, West Palm Beach, Florida, USA
Joel L. Cohen
Affiliation:
AboutSkin Dermatology and Dermsurgery, Englewood, Colorado, USA
Alastair Carruthers
Affiliation:
Department of Dermatology, University of British Columbia, Vancouver BC, Canada
Anthony B. Ward
Affiliation:
University Hospital of North Staffordshire
Michael P. Barnes
Affiliation:
Hunters Moor Regional Neurological Rehabilitation Centre
Get access

Summary

Introduction

The cosmetic uses of botulinum toxin (BoNT) are the most commonly used of its applications. Interest started after the effect of BoNT was shown in the treatment of blepharospasm and the first description of botulinum toxin for treatment of glabellar frown lines was in 1992. At that time, the use of this potent neurotoxin for cosmetic indications was an interesting footnote to treatments for strabismus, torticollis and other dystonias. Subsequently, physicians began to study and use the botulinum toxins for a variety of cosmetic indications. Today, BoNT is the most commonly performed cosmetic procedure in the world. Understanding how these toxins are used in this arena is essential to any discussion of the botulinum toxins.

Dilution of the toxin for cosmetic purposes

For the purposes of this chapter, the dilution of BoNT will be described in units of the BOTOX® brand of type A toxin. Oculoplastic specialists usually inject using a 1 ml dilution per 100 units of BOTOX®, whereas dermatologists and plastic surgeons vary in their practice towards a general range from 1 ml to 4 ml per 100 units. Variations in concentration affect the concentration gradient between the toxin and its environment. In the forehead, for instance, a dilute concentration may be preferable in order to increase migration, but, in general, clinicians use lower volumes to minimize the risk of this getting into unplanned areas.

Type
Chapter
Information
Clinical Uses of Botulinum Toxins , pp. 328 - 348
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Carruthers, J. D. and Carruthers, J. A. (1992). Treatment of glabellar frown lines with Clostridium botulinum-A exotoxin. Journal of Dermatologic Surgery and Oncology, 18(1), 17–21.CrossRefGoogle Scholar
Hsu, T. S., Dover, J. S. and Arndt, K. A. (2004). Effect of volume and concentration on the diffusion of botulinum exotoxin A. Archives of Dermatology, 140(11), 1351–4.CrossRefGoogle ScholarPubMed
Dover, J. S. and Arndt, K. A. (2002). Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial. Arch. Dermatol., 138(4), 510–14.Google Scholar
Lewis, C. (2002). Botox cosmetic: a look at looking good. FDA Consumer, 36(4), 11–13.Google Scholar
Goodman, G. (2003). Diffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis dermatologic surgery. Dermatologic Surgery, 29(5), 533–8.Google Scholar
Finn, C., Cox, S. E. and Earl, F. (2003). Social implications of hyperfunctional facial lines. Dermatol. Surg., 29, 450–5.CrossRefGoogle Scholar
Carruthers, A., Carruthers, J. and Said, S. (2005). Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. Dermatologic Surgery, 31(04), 414–22.CrossRefGoogle ScholarPubMed
Carruthers, A. and Carruthers, J. (2005). Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatologic Surgery, 31(10), 1297–303.CrossRefGoogle ScholarPubMed
Carruthers, J. A., Lowe, N. J., Menter, M. A., Gibson, J., Nordquist, M., Mordaunt, J., Walker, P. and Eadie, N. (2002). A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. Journal of American Academy of Dermatology, 46, 840–9.CrossRefGoogle ScholarPubMed
Carruthers, A., Carruthers, J. and Cohen, J. (2003). A prospective, double-blind, randomized, parallel group, dose-ranging study of BOTOX® in female subjects with horizontal forehead rhytids. Dermatologic Surgery, 29, 462–7.Google Scholar
Kane, M. A. (2003). Classification of crow's feet patterns among caucasian women: the key to individualizing treatment. Plastic and Reconstructive Surgery, 112(Suppl. 5), S33–S39.CrossRefGoogle ScholarPubMed
Goldman, M. (2003). Festoon formation after infraorbital botulinum-A toxin: a case report. Dermatologic Surgery, 29(5), 560.Google ScholarPubMed
Lowe, N.et al. (2005). Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Dermatologic Surgery, 31(3), 257–62.CrossRefGoogle ScholarPubMed
Cohen, J. and Dayan, S. (2005). Botulinum toxin type A in the treatment of dermatochalasis: a prospective study evaluating temporal brow elevation. American Academy of Dermatology, 52(Suppl. 3), 86.Google Scholar
Flynn, T., Carruthers, J. A., Carruthers, A. and Clark, R. (2003). Botulinum A toxin (BOTOX®) in the lower eyelid: dose-finding study. Dermatol. Surg., 29(9), 943–50.Google Scholar
Tamura, B., Odo, M., Chang, B., Cuce, L. and Flynn, T. (2005). Treatment of nasal wrinkles with botulinum toxin. Dermatologic Surgery, 31(03), 271–5.CrossRefGoogle ScholarPubMed
Carruthers, J. and Carruthers, A. (1999). Practical cosmetic Botox® techniques. Journal of Cutaneous Medicine and Surgery, 3(Suppl. 4), S49–52.CrossRefGoogle Scholar
Pessa, J. E. (1992). Improving the acute nasolabial angle and medial nasolabial fold by levator alae muscle resection. Annals of Plastic Surgery, 29(1), 23–30.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×